- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02797418
"Cognitus & Moi": a New Cognitive Remediation Tool (COGNITUS)
August 6, 2021 updated by: Hôpital le Vinatier
"Cognitus & Moi": a New Cognitive Remediation Tool for Children With Intellectual Deficiency With Behavioral Disorders
Holders children with intellectual disabilities have great difficulty in adapting to social situations and relationships.Cognitive impairment associated with intellectual disability are important factors to understand their difficulties in processing social information.
In the field of recognition of facial emotions in particular, basic cognitive processes such as visuospatial and attentional functions, are heavily involved.Cognitive remediation is a management tool widely used by practitioners to help patients who experience cognitive difficulties.
Currently, no program can meet specific and validated the problems are children with intellectual disabilities manner in their daily functioning.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Cognitus & ME is a remediation program focused on attentional functions and visuospatial, to limit the presence of behavioral disorders among children with intellectual disabilities.The main objective is to validate the effectiveness of Cognitus & ME program on behavioral disorders in children with intellectual disabilities (with or without autism spectrum disorder associated).
Study Type
Interventional
Enrollment (Actual)
18
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Lyon
-
Bron, Lyon, France, 69678
- Demily Caroline
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
5 years to 13 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Children with intellectual deficiency (5-13 years) (40 < total IQ < 75) with or without autism spectrum disorders
- Native French speaker
- Clinically stable
- Parental consent
Exclusion Criteria:
- visual or auditory disorder
- history of neurological illness or trauma
- Absence of language
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Cognitus and Me
Cognitus & Me is a cognitiv remediation program focused on the functions of attention and visuospatial that is to say that can move in space, to perceive objects of our environment and organize them, to mentally imagine a physically absent operation object very involved in social behavior, in order to limit the presence of behavioral disorders among children with intellectual disabilities.
|
Comparison between a cognitive remediation program (Cognitus and Me") (groupe 1) and a training group of fine motor skills (group 2)
|
ACTIVE_COMPARATOR: control group
the control management that involves fine motor skills and research computer information,management control is usually done
|
Comparison between a cognitive remediation program (Cognitus and Me") (groupe 1) and a training group of fine motor skills (group 2)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Aberrant Behavior Checklist scale
Time Frame: 6 months
|
Change in sub-score " hyperactivity / non compliance " (scale " Aberrant Behavior Checklist ") (completed by parents or the educational team).
This measure is repeated at the end of the intervention to highlight the impact of the " Cognitus and Me " program, and 6 months later to investigate the possible long-lasting effects of the benefits.
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
MDI-C scale ( Multiscore Depression Inventory for Children scale)
Time Frame: 6 months
|
The Aberrant Behavior Checklist-Community (ABC-C; Aman & Singh, 1994) is a rating scale that measures the severity of a range of problem behaviors commonly observed in individuals with intellectual and developmental disabilities
|
6 months
|
KIDSCREEN-27 scale
Time Frame: 6 months
|
The KIDSCREEN-27 with five dimensions resulted.
All five dimensions are Rasch scales: Physical Well-Being (5 items), Psychological Well-Being (7 items), Autonomy & Parents (7 items), Peers & Social Support (4 items), and School Environment (4 items).
|
6 months
|
Vineland 2 scale (Vineland Adaptive Behavior Scale)
Time Frame: 6 months
|
A measure of adaptive behavior from birth to adulthood
|
6 months
|
ABC scale (Irritability and social withdrawal)
Time Frame: 6 months
|
This measure is repeated at the end of the intervention to highlight the impact of the " Cognitus and Me " program, and 6 months later to investigate the possible long-lasting effects of the benefits
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: DEMILY DR CAROLINE, MD PH, Le Vinatier Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 14, 2016
Primary Completion (ACTUAL)
April 30, 2021
Study Completion (ACTUAL)
April 30, 2021
Study Registration Dates
First Submitted
June 8, 2016
First Submitted That Met QC Criteria
June 8, 2016
First Posted (ESTIMATE)
June 13, 2016
Study Record Updates
Last Update Posted (ACTUAL)
August 13, 2021
Last Update Submitted That Met QC Criteria
August 6, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015-A00858-41
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Retardation
-
Tokat Gaziosmanpasa UniversityCompletedProfound Mental Retardation
-
Hospices Civils de LyonUnknownX-linked Mental RetardationFrance
-
Ono Academic CollegeCompletedMental Retardation and Developmental Disabilities With Organic Condition
-
University of California, DavisUniversity of Alberta; St. Justine's HospitalRecruitingNeurobehavioral Manifestations | Genetic Diseases, X-Linked | Intellectual Disability | Fragile X Syndrome | Sex Chromosome Disorders | Fragile X Mental Retardation Syndrome | Trinucleotide Repeat Expansion | Fra(X) Syndrome | FXS | Mental Retardation, X LinkedUnited States, Canada
-
Instituto Politécnico de Castelo BrancoCompletedMental Retardation and Developmental Disabilities With No Organic Condition
-
Icahn School of Medicine at Mount SinaiRecruitingAutism Spectrum Disorder | DDX3X | Mental Retardation, X-linked 102United States
-
Central Hospital, Nancy, FranceCompletedGrowth Retardation
-
Tanzania Food and Drugs AuthorityUniversity Ghent; International Foundation for Science (IFS); The Nelson Mandela... and other collaboratorsCompleted
-
University of AlbertaSt. Justine's HospitalRecruitingNeurobehavioral Manifestations | Genetic Diseases, X-Linked | Mental Retardation, X-Linked | Intellectual Disability | Fragile X Syndrome | Sex Chromosome Disorders | Fragile X Mental Retardation Syndrome | Trinucleotide Repeat Expansion | Fra(X) Syndrome | FXSCanada
-
Neurogen Brain and Spine InstituteWithdrawn
Clinical Trials on Cognitive remediation program
-
Hospices Civils de LyonRecruitingBreast Cancer | Cognitive RemediationFrance
-
Assistance Publique Hopitaux De MarseilleCompletedChildren Born Extremely Premature | Disturbance of Visuo-spatial Working MemoryFrance
-
Hôpital le VinatierTerminated
-
University of DeustoCompletedMultiple SclerosisSpain
-
Hôpital le VinatierRecruitingA Computer-based Cognitive Remediation Program for Adults With Intellectual Disability (REHABILITUS)Intellectual DisabilityFrance
-
New York Institute of TechnologyCompletedParkinson DiseaseUnited States
-
University of DeustoCompletedPARKINSON DISEASE (Disorder)Spain
-
University of DeustoCompleted
-
Queen's UniversityCompleted
-
Yale UniversityNational Institute on Drug Abuse (NIDA)CompletedDrug Use DisordersUnited States